Vystar Adds Fluid Energy Conversion Into Planned RxAir Spin-Off
Vystar Corporation (OTCQB: VYST) announced the integration of its subsidiary Fluid Energy Conversion, Inc. (FEC) into the RxAir spin-off, set for early 2022. This strategic move aims to enhance research and development in air and water purification, leveraging FEC's patented Hughes Reactor technology. The spin-off will allow Vystar to concentrate on its retail business and environmentally friendly products. Dr. Bryan Stone will lead RxAir NewCo, focusing on advancing air purification methods and addressing critical clean water needs due to severe droughts.
- Addition of FEC technology into the RxAir spin-off for enhanced air and water purification R&D.
- Dr. Bryan Stone appointed as CEO of RxAir NewCo, benefiting from his expertise in healthcare and product development.
- FEC's Hughes Reactor technology offers innovative approaches to air and water purification.
- None.
- FEC patented technology has potential for applications in multiple industries
- FEC to prioritize air and water purification R&D
Worcester, MA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Vystar® Corporation’s (OTCQB: VYST) Board of Directors has approved plans to add its Fluid Energy Conversion, Inc.(FEC), subsidiary into the previously announced planned spin-off of its RxAir® UV light air purification subsidiary into a publicly traded entity (RxAir NewCo). This is expected to occur in early 2022. The addition of FEC to the RxAir spin-off will not change the previously announced ratio of the dividend of stock in RxAir NewCo that is planned to be issued to Vystar shareholders of record. The spin-off will enable Vystar to focus on its Rotmans Furniture retail business and Vytex® latex and rubber products, while allowing RxAir NewCo to pursue strategic partnerships for the funding, research, development and commercialization of FEC’s patented technologies across multiple industries.
“The FEC technology has a potential for applications in many different areas, including for RxAir, so it makes sense from an operational and investment perspective to pair it with the RxAir spin-out and keep it all under one management team,” stated Steve Rotman, CEO of Vystar.
Vystar plans to appoint Bryan Stone, MD, as CEO of RxAir NewCo to oversee both businesses. Dr. Stone has been involved in the research and marketing of RxAir and R&D of FEC with its founder Nathaniel Hughes prior to FEC’s acquisition by Vystar. Dr. Stone is a member of the Vystar Board of Directors and a long-term advisor to Vystar on product development for the healthcare industry. He also is the Chairman of Medicine Emeritus at Desert Regional Medical Center in Palm Springs, Calif., and the Medical Director at multiple DaVita Dialysis Centers.
FEC developed and patented the Hughes Molecular Mixer and Catalytic Reactor (H-MMCR™ or Hughes Reactor), a highly efficient, cost effective, mass producible energy conversion device. This breakthrough technology converts the molecular and dynamic flow energies of gas or liquid directly into a controlled ultrasonic energy field. Powerful ultrasound is used to establish a uniform, controlled cavitation field. This cavitation field adds ionic energy. The Hughes Reactor can push chemical reactions or improve ignition by raising molecular energy levels to high states of excitement. The process has virtually no limits and derives these energies from the flow of molecules themselves. This offers the opportunity for cost-effective applications in areas never previously thought possible.
For several years following Hughes’ death, FEC activities halted. However, FEC plans to resume R & D, prioritizing two areas for 2022:
- Air Purification - Applying FEC’s patented Hughes Reactor to create a vortex and increased air turbulence within the RxAir units to further enhance RxAir’s performance in inactivating viruses, bacteria and other pathogens, and
- Water Purification - Exploring how the Hughes Reactor technology can be used to improve water quality by destroying water-borne viruses, bacteria and other biologics, as well as hard water neutralization, (aka water softening).
Other potential applications of the Hughes Reactor for future R&D and commercialization include, but are not limited, to:
- Metering
- Enhance Combustion for Natural Gas, Petroleum and Biofuels
- Reverse Osmosis/Desalination
- Chemical Mixing
- Water Atomization
FEC is seeking prospective partners interested in furthering applications in the above fields.
Water and air are two of the most essential requirements for life. Due to COVID, the public is now more aware than ever of the risks of airborne viruses and bacteria, and the critical need for air free of biologic pathogens for each of the 23,000 breaths each person inhales per day. The Environmental Protection Agency (EPA) notes that indoor air quality has ramifications beyond just transmission of diseases: “Qualitative and quantitative evidence demonstrating the relationship between indoor air quality (IAQ) and human performance and productivity has become more robust. Studies demonstrate that improved IAQ increases productivity and improves the performance of mental tasks, such as concentration and recall in both adults and children.”1 The EPA also notes, “Asthma is the leading cause of absenteeism in schools, which hinders classroom achievement.2”
Dr. Stone stated: “While we have new RxAir products in the design phase, we would like to harness this innovative FEC technology to advance air purification in new ways. Our research indicates FEC’s ultrasonic energy technology may have the potential to safely and more effectively purify air with fewer limitations than HEPA filters and UV-C light.”
Additionally, severe droughts in the Western United States have placed a spotlight on the importance of a ready supply of clean water and the need to find new ways to reduce use, recycle and purify this precious resource. FEC’s patented technologies have the potential to be game-changing in both areas. FEC’s Hughes Reactor technology operates at the molecular level to convert flow energy of water into ultrasound and cavitation energy, which are well known to enhance water treatment and purification.
“I am looking forward to focusing more resources on these areas in the future and sharing details of our progress as we apply this technology to meet the challenges of improving air and water purification,” stated Dr. Stone.
For information on FEC partnerships, contact info@Rxair.com or 508-791-9114.
Follow us on social media:
Twitter: @VystarCompany @RxAir
Facebook: @RxAir
Instagram: @rxair_air_purification
1 For a summary of the impact of indoor environmental quality on work and school performance, as well as other IAQ research findings, see the IAQ Scientific Findings Resource Bank (SFRB) established as a cooperative venture between EPA and the Lawrence Berkeley National Laboratory: Accessible at http://www.iaqscience.lbl.gov/performance-summary.html
2 Haverin-Shaughnessy U., M. Turunen, et al. 2012. “Sixth grade pupils’ health and performance and indoor environmental quality in Finnish school buildings.” British Journal of Education Research 2(1) 42-58.
# # #
About Vystar Corporation:
Based in Worcester, Mass., Vystar® Corp. (OTCQB: VYST) is the majority owner of Rotmans Furniture and Flooring and environmentally friendly technologies and products to improve lives, including RxAir® UV light air purification products that destroy harmful airborne viruses and pathogens, Vytex® Natural Rubber Latex (NRL), and Fluid Energy Solutions. Vytex is a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex for a stronger, more durable, yet environmentally safe, "green" and fully biodegradable product that can be used in a broad range of consumer and medical products. For more information, visit www.vystarcorp.com.
Contacts:
Media: Julie Shepherd, Accentuate PR, 847_275_3643, Julie@accentuatepr.com
Investors: Lee Howley, lhowley@vytex.com, 508_791_9114
Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, company value, spin-off logistics, plans, pricing and timing, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.
FAQ
What is the spin-off plan for Vystar Corporation in 2022?
Who will lead the RxAir NewCo after the spin-off?
What technology is Vystar focusing on for air and water purification?
How does FEC's technology benefit air and water purification?
What industries can benefit from FEC's patented technology?
